Business Context and Reporting Period
This Form 10-Q covers Unitrin, Inc. (referred to as KEMPER Corp in metadata, but identified as Unitrin in the filing text) for the quarterly period ended June 30, 2002. The company operates through five segments: Multi Lines Insurance, Specialty Lines Insurance, Life and Health Insurance, Consumer Finance, and Unitrin Direct. A significant corporate event during the period was the acquisition of the personal lines property and casualty business of Kemper Insurance Companies on June 28, 2002.
Key Financial Metrics
| Metric (Dollars in Millions) | Six Months Ended June 30, 2002 | Six Months Ended June 30, 2001 |
|---|---|---|
| Total Revenues | $1,035.3 | $1,511.8 |
| Net Income | $13.6 | $372.9 |
| Net Income Per Share | $0.20 | $5.52 |
| Operating Cash Flow | $97.8 | $72.0 |
| Total Assets | $7,374.3 | $7,133.7 |
| Total Liabilities | $5,356.2 | $5,216.9 |
| Shareholders' Equity | $2,018.1 | $1,916.8 |
| Notes Payable | $216.0 | $254.8 |
Segment Performance (Six Months 2002):
- Multi Lines Insurance: Operating Loss of $14.2 million (improved from $21.7 million loss in 2001).
- Specialty Lines Insurance: Operating Loss of $2.1 million (improved from $11.4 million loss in 2001).
- Life and Health Insurance: Operating Profit of $41.4 million (decreased from $46.7 million in 2001).
- Consumer Finance: Operating Profit of $16.2 million (increased from $13.4 million in 2001).
- Unitrin Direct: Operating Loss of $17.2 million (increased from $10.4 million loss in 2001).
Material Changes vs. Prior Period
Revenue and Profit Decline: Net income dropped significantly from $372.9 million in 2001 to $13.6 million in 2002. This decline is primarily attributable to the absence of a one-time pre-tax gain of $562.1 million recognized in 2001 from the sale of Unitrin's investment in Litton Industries (acquired by Northrop Grumman). Excluding this non-recurring gain, core operating results showed improvement in several segments.
Investment Income: Net investment income decreased to $112.8 million in 2002 from $115.7 million in 2001 due to lower yields. Net gains on sales of investments turned negative at $(1.3) million in 2002 compared to $562.6 million in 2001.
Equity in Investees: Equity in net income of investees turned negative at $(5.1) million in 2002, driven by losses from UNOVA, Inc., compared to a positive $7.1 million in 2001.
Acquisition: The company acquired Kemper's personal lines business for approximately $42.0 million. This transaction did not materially impact results for the quarter ended June 30, 2002, but will be reported as a separate segment starting in Q3 2002.
Guidance, Outlook, and Risks
Outlook:
- Multi Lines Insurance: Management anticipates continued improvement in 2002 but notes profitability may not be reached until 2003.
- Unitrin Direct: Expected to produce operating losses for at least the next few years due to up-front marketing costs and scale issues.
- Kemper Acquisition: Profitability is expected to be limited for the next few years due to performance-based bonus obligations to Kemper.
Risks and Contingencies:
- Legal Proceedings: The company is involved in class action lawsuits regarding the historical use of race as an underwriting factor in life insurance. A settlement agreement was announced in May 2002, with a preliminary approval pending. While a liability was recorded in 2000, the final cost remains uncertain.
- Investment Concentration: A significant portion of equity securities ($1,215.5 million) is concentrated in Northrop Grumman stock. Subsequent to June 30, 2002, the fair value of these investments decreased by $184.7 million.
- Market Risk: The company faces interest rate risk on fixed maturities and consumer finance receivables, and equity price risk on its stock holdings.
Accounting Changes: The company adopted SFAS No. 142 (Goodwill) on January 1, 2002, ceasing the amortization of goodwill and instead testing it for impairment. This change improved reported segment operating profits for prior periods when restated.
Investor Verification Checklist
- One-Time Gains: Verify the impact of the $562.1 million 2001 Litton sale gain on year-over-year comparisons to understand core operational performance.
- Investment Valuation: Monitor the fair value of the concentrated Northrop Grumman holdings, which declined $184.7 million post-period end.
- Legal Settlement: Track the final accounting of the race-based underwriting settlement to assess potential future charges.
- Segment Profitability: Review the timeline for Multi Lines Insurance and Unitrin Direct to reach profitability as projected by management.
- Debt Maturity: Note the $440 million revolving credit facility expires September 1, 2002, though the company issued $300 million in senior notes in July 2002 to repay borrowings.